Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for January 14th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 14th:

Janus Henderson Group plc (JHG - Free Report) :This asset management company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 4.1% over the last 60 days.

Janus Henderson has a price-to-earnings ratio (P/E) of 9.57, compared with 13.70 for the industry. The company possesses a Value Score of A.

Penske Automotive Group, Inc. (PAG - Free Report) : This transportation services company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.

Penske Automotive has a price-to-earnings ratio (P/E) of 8.37, compared with 12.70 for the industry. The company possesses a Value Score of A.

Ternium S.A. (TX - Free Report) : This manufacturer of various steel products has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.

Ternium has a price-to-earnings ratio (P/E) of 9.02, compared with 25.70 for the industry. The company possesses a Value Score of A.

Ternium S.A. PE Ratio (TTM)

Ternium S.A. PE Ratio (TTM)

Ternium S.A. pe-ratio-ttm | Ternium S.A. Quote

H&R Block, Inc. (HRB - Free Report) : This provider of assisted income tax return preparation services has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 21.9% over the last 60 days.

H&R Block has a price-to-earnings ratio (P/E) of 9.64, compared with 28.90 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>